Should androgen supplementation be used for poor ovarian response in IVF?

Human Reproduction

Volumn 27, Issue 3, 2012, Pages 637-640

  Sunkara, Sesh Kamal ^a   Coomarasamy, Arri ^b   Arlt, Wiebke ^b   Bhattacharya, Siladitya ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

androgens; IVF treatment; poor ovarian response

Indexed keywords

ESTRADIOL; ESTROGEN; PRASTERONE; TESTOSTERONE;

CELL PROLIFERATION; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GRANULOSA CELL; HORMONAL THERAPY; HUMAN; LIVE BIRTH; META ANALYSIS (TOPIC); NONHUMAN; OOCYTE; OVARY; OVARY FOLLICLE DEVELOPMENT; OVARY INSUFFICIENCY; OVULATION INDUCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHESUS MONKEY; UNCERTAINTY;

EID: 84857209270     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der464     Document Type: Review

References (40)

1. Arlt W, Justl HG, Callies F, Reincke M, Hüler D, Oettel M, Ernst M, Schulte HM, Allolio B. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 1998; 83:1928-1934. (Pubitemid 28496318)
2. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999;341:1013-1020. (Pubitemid 29451796)
3. Barad D, Gleicher N. Increased oocyte production after treatment with dehydroepiandrosterone. Fertil Steril 2005;84:756.
4. Barad D, Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod 2006;21:2845-2849. (Pubitemid 44566996)
5. Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet 2007;24:629-634.
6. Botting B, Dunnell K. Trends in fertility and contraception in the last quarter of the 20th century. Natl Stat Popul Trends 2000;100:32-39.
7. Casson PR, Santoro N, Elkind-Hirsch K, Carson SA, Hornsby PJ, Abraham G, Buster JE. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertil Steril 1998;70:107-110. (Pubitemid 28294631)
8. Casson PR, Lindsay MS, Pisarska MD, Carson SA, Buster JE. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum Reprod 2000;15:2129-2132.
9. Diamond P, Cusan L, Gomez JL, Béanger A, Labrie F. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol 1996;150:S43-S50.
10. Dierschke DJ, Chaffin CL, Hutz RJ. Role and site of estrogen action in follicular atresia. Trends Endocrinol Metab 1994;5:215-219. (Pubitemid 24266939)
11. Fáregues F, Peñarrubia J, Creus M, Manau D, Casals G, Carmona F, Balasch J. Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial. Hum Reprod 2009; 24:349-359.
12. Haning RV Jr, Hackett RJ, Flood CA, Loughlin JS, Zhao QY, Longcope C. Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins. J Clin Endocrinol Metab 1993;76:1301-1307. (Pubitemid 23155454)
13. HFEA Authority. http://www. hfea. gov. uk/ivf-figures-2006. html (22 April 2011, date last accessed).
14. Horie K, Takakura K, Fujiwara H, Suginami H, Liao S, Mori T. Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression. Hum Reprod 1992;7:184-190.
15. IVF Worldwide Survey. Poor responders: how to define, diagnose and treat? www. IVF-Worldwide. com (8 August 2010, date last accessed).
16. Keay SD, Liversedge NH, Mathur RS, Jenkins JM. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1997;104:521-527. (Pubitemid 27240414)
17. Kim CH, Howles CM, Lee HA. The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertil Steril 2011;95:679-683.
18. Koering MJ, Danforth DR, Hodgen GD. Early follicle growth in the juvenile macaca monkey ovary: the effects of estrogen priming and follicle-stimulating hormone. Biol Reprod 1994;50:686-694. (Pubitemid 24058530)
19. Kyrou D, Kolibianakis E, Venetis CA, Papanikolaou EG, Bontis J, Tarlatzis BC. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril 2009;91:749-766.
20. Loutradis D, Vomvolaki E, Drakakis P. Poor responder protocols for in-vitro fertilization: options and results. Curr Opin Obstet Gynecol 2008; 20:374-378.
21. Massin N, Cedrin-Durnerin I, Coussieu C, Galey-Fontaine J, Wolf JP, Hugues JN. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique-a prospective, randomized, double-blind study. Hum Reprod 2006;21:1204-1211.
22. Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360-1367. (Pubitemid 24181005)
23. Nielsen ME, Rasmussen IA, Kristensen SG, Christensen ST, Mälgärd K, Wreford Andersen E, Byskov AG, Yding Andersen C. In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA. Mol Hum Reprod 2011;17:63-70.
24. Pandian Z, McTavish AR, Aucott L, Hamilton MP, Bhattacharya S. Intervention for poor responders to controlled ovarian hyperstimulation in IVF. Cochrane Database Syst Rev 2010;I:CD004379.
25. Payne RW, Runser RH. Quantitative response of the rat ovary to pituitary gonadotropin as modified by estrogen. Endocrinology 1959;65:383-388.
26. Ryan KJ, Petro Z, Kaiser J. Steroid formation by isolated and recombined ovarian granulosa and tehcal cells. J Clin Endocrinol Metab 1968; 28:355-358.
27. Sen A, Hammes SR. Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol 2010; 24:1393-1403.
28. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-688.
29. Smith BD, Bradbury JT. Ovarian weight response to varying doses of estrogens in intact and hypophysectomized rats. Proc Soc Exp Biol Med 1961;107:946-949.
30. Sunkara SK, Tuthill J, Khairy M, El-Toukhy T, Coomarasamy A, Khalaf Y, Braude P. Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis. Reprod Biomed Online 2007;15:539-546. (Pubitemid 350167076)
31. Sunkara SK, Coomarasamy A. Androgen pre-treatment in poor responders undergoing controlled ovarian stimulation and IVF treatment. Fertil Steril 2011;95:73-74.
32. Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 2000;73:667-676. (Pubitemid 30154101)
33. Suzuki T, Sasano H, Kimura N, Tamura M, Fukaya T, Yajima A, Nagura H. Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes. Human Reprod 1994;9:1589-1595. (Pubitemid 24291067)
34. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 2003;9:61-76. (Pubitemid 36305584)
35. Te Velde ER. Ovarian ageing and postponement of childbearing. Maturitas 1998;30:103-104. (Pubitemid 28491349)
36. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998;101:2622-2629. (Pubitemid 28294570)
37. Weil SJ, Vendola K, Zhou J, Adesanya OO, Wang J, Okafor J, Bondy CA. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 1998;83:2479-2485. (Pubitemid 28503050)
38. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999;84:2951-2956. (Pubitemid 30642034)
39. Wiser A, Gonen O, Ghetler Y, Shavit T, Berkovitz A, Shulman A. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod 2010; 25:2496-2500.
40. Zelinski-Wooten MB, Stouffer RL. Steroid receptors and action in the primate follicle. Trends Endocrinol Metab 1996;7:177-183. (Pubitemid 26239467)